1. Home
  2. TGTX vs GGB Comparison

TGTX vs GGB Comparison

Compare TGTX & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

N/A

Current Price

$64.36

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Logo Gerdau S.A.

GGB

Gerdau S.A.

N/A

Current Price

$4.45

Market Cap

8.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TGTX
GGB
Founded
1993
1901
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.8B
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
TGTX
GGB
Price
$64.36
$4.45
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
★ $69.43
$5.61
AVG Volume (30 Days)
1.8M
★ 18.4M
Earning Date
11-09-2026
10-26-2026
Dividend Yield
N/A
★ 3.20%
EPS Growth
★ 1746.67
N/A
EPS
★ 0.52
N/A
Revenue
★ $2,785,000.00
N/A
Revenue This Year
$61.95
$2.01
Revenue Next Year
$35.55
$4.67
P/E Ratio
$120.60
★ $13.89
Revenue Growth
N/A
★ N/A
52 Week Low
$26.76
$3.14
52 Week High
$68.03
$5.48

Technical Indicators

Market Signals
Indicator
TGTX
GGB
Relative Strength Index (RSI) 60.53 41.92
Support Level $52.12 $4.35
Resistance Level $63.60 $4.91
Average True Range (ATR) 3.52 0.14
MACD 0.14 -0.02
Stochastic Oscillator 64.62 37.17

Price Performance

Historical Comparison
TGTX
GGB

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as Semi-finished products (Billets, Blooms and Slabs), Special bar quality, Common Long Rolled Products, Dawn products, Merchant bar, Beams, Rebar, Piling, Iron Ore and Others. The company's geographical segment includes Brazil Segment; North America Segment; and South America Segment. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.

Share on Social Networks: